Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Phenanthrenes from Juncus Compressus Jacq. with Promising Antiproliferative and Anti-HSV-2 Activities.

Bús C, Kúsz N, Jakab G, Senobar Tahaei SA, Zupkó I, Endrész V, Bogdanov A, Burián K, Csupor-Löffler B, Hohmann J, Vasas A.

Molecules. 2018 Aug 20;23(8). pii: E2085. doi: 10.3390/molecules23082085.

2.

Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.

Lantos I, Endrész V, Virok DP, Szabó A, Lu X, Mosolygó T, Burián K.

Biomed Res Int. 2018 Mar 25;2018:8325915. doi: 10.1155/2018/8325915. eCollection 2018.

3.

Growth characteristics of Chlamydia trachomatis in human intestinal epithelial Caco-2 cells.

Lantos I, Virok DP, Mosolygó T, Rázga Z, Burián K, Endrész V.

Pathog Dis. 2018 Apr 1;76(3). doi: 10.1093/femspd/fty024.

PMID:
29635314
4.

N-acetyl-cysteine increases the replication of Chlamydia pneumoniae and prolongs the clearance of the pathogen from mice.

Kókai D, Mosolygó T, Virók DP, Endrész V, Burián K.

J Med Microbiol. 2018 Mar 9. doi: 10.1099/jmm.0.000716. [Epub ahead of print]

PMID:
29521616
5.

A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies.

Virók DP, Eszik I, Mosolygó T, Önder K, Endrész V, Burián K.

J Virol Methods. 2017 Apr;242:46-52. doi: 10.1016/j.jviromet.2017.01.007. Epub 2017 Jan 16.

PMID:
28093274
6.

Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.

Deshpande V, Krishnan R, Philip S, Faludi I, Ponnusamy T, Thota LN, Endresz V, Lu X, Kakkar VV, Mundkur LA.

Cardiovasc Ther. 2016 Oct;34(5):314-24. doi: 10.1111/1755-5922.12201.

PMID:
27241889
7.

Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression.

Buzás K, Marton A, Vizler C, Gyukity-Sebestyén E, Harmati M, Nagy K, Zvara Á, Katona RL, Tubak V, Endrész V, Németh IB, Oláh J, Vígh L, Bíró T, Kemény L.

J Invest Dermatol. 2016 Apr;136(4):862-5. doi: 10.1016/j.jid.2015.12.032. Epub 2015 Dec 29. No abstract available.

8.

High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells.

Eszik I, Lantos I, Önder K, Somogyvári F, Burián K, Endrész V, Virok DP.

J Microbiol Methods. 2016 Jan;120:15-22. doi: 10.1016/j.mimet.2015.11.010. Epub 2015 Nov 11.

PMID:
26578244
9.

Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice.

Xia M, Chen D, Endresz V, Lantos I, Szabo A, Kakkar V, Lu X.

PLoS One. 2015 Apr 1;10(4):e0123393. doi: 10.1371/journal.pone.0123393. eCollection 2015.

10.

Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4(+) cells in C57BL/6N mice.

Mosolygó T, Szabó AM, Balogh EP, Faludi I, Virók DP, Endrész V, Samu A, Krenács T, Burián K.

Vaccine. 2014 Sep 8;32(40):5228-33. doi: 10.1016/j.vaccine.2014.07.039. Epub 2014 Jul 29.

PMID:
25077421
11.

Expression of Chlamydia muridarum plasmid genes and immunogenicity of pGP3 and pGP4 in different mouse strains.

Mosolygó T, Faludi I, Balogh EP, Szabó ÁM, Karai A, Kerekes F, Virók DP, Endrész V, Burián K.

Int J Med Microbiol. 2014 May;304(3-4):476-83. doi: 10.1016/j.ijmm.2014.02.005. Epub 2014 Feb 19.

PMID:
24631212
12.

Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.

Xia M, Chen D, Endresz V, Faludi I, Szabo A, Gonczol E, Kakkar V, Lu X.

PLoS One. 2013 Dec 13;8(12):e81056. doi: 10.1371/journal.pone.0081056. eCollection 2013. Erratum in: PLoS One. 2014;9(5):e99474.

13.

IL-17E production is elevated in the lungs of Balb/c mice in the later stages of Chlamydia muridarum infection and re-infection.

Mosolygó T, Spengler G, Endrész V, Laczi K, Perei K, Burián K.

In Vivo. 2013 Nov-Dec;27(6):787-92.

PMID:
24292583
14.

Application of DNA chip scanning technology for automatic detection of Chlamydia trachomatis and Chlamydia pneumoniae inclusions.

Bogdanov A, Endrész V, Urbán S, Lantos I, Deák J, Burián K, Önder K, Ayaydin F, Balázs P, Virok DP.

Antimicrob Agents Chemother. 2014;58(1):405-13. doi: 10.1128/AAC.01400-13. Epub 2013 Nov 4.

15.

Isocitrate lyase encoding plasmids in BCG cause increased survival in ApoB100-only LDLR-/- mice.

Szabo AM, Endresz V, Somogyvari F, Miczak A, Faludi I.

Mol Biol Rep. 2013 Aug;40(8):4721-5. doi: 10.1007/s11033-013-2568-5. Epub 2013 May 8.

PMID:
23653002
16.

Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.

Mosolygó T, Korcsik J, Balogh EP, Faludi I, Virók DP, Endrész V, Burián K.

Inflamm Res. 2013 May;62(5):451-60. doi: 10.1007/s00011-013-0596-1. Epub 2013 Feb 6.

PMID:
23385305
17.

Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.

Lu X, Xia M, Endresz V, Faludi I, Szabo A, Gonczol E, Mundkur L, Chen D, Kakkar V.

Atherosclerosis. 2012 Nov;225(1):56-68. doi: 10.1016/j.atherosclerosis.2012.07.021. Epub 2012 Aug 18.

PMID:
22959702
18.

Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice.

Lu X, Xia M, Endresz V, Faludi I, Mundkur L, Gonczol E, Chen D, Kakkar VV.

Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2358-71. doi: 10.1161/ATVBAHA.112.253179. Epub 2012 Jul 26.

PMID:
22837469
19.

Human cytomegalovirus neutralising antibodies and increased risk of coronary artery disease in Indian population.

Mundkur LA, Shivanandan H, Hebbagudi S, Endrész V, Varma M, Rao V, Gonczol E, Kakkar VV.

Heart. 2012 Jul;98(13):982-7. doi: 10.1136/heartjnl-2012-301850.

PMID:
22668865
20.

Generation of targeted Chlamydia trachomatis null mutants.

Kari L, Goheen MM, Randall LB, Taylor LD, Carlson JH, Whitmire WM, Virok D, Rajaram K, Endresz V, McClarty G, Nelson DE, Caldwell HD.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7189-93. doi: 10.1073/pnas.1102229108. Epub 2011 Apr 11.

Supplemental Content

Loading ...
Support Center